Sung-Han Hsiao

发表

Licochalcone A Selectively Resensitizes ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs.

T. Hung, S. Ambudkar, Chung-Pu Wu, 2020, Journal of natural products.

MY-5445, a phosphodiesterase type 5 inhibitor, resensitizes ABCG2-overexpressing multidrug-resistant cancer cells to cytotoxic anticancer drugs.

T. Hung, S. Ambudkar, Chung-Pu Wu, 2020, American journal of cancer research.

Alpha-Mangostin Reverses Multidrug Resistance by Attenuating the Function of the Multidrug Resistance-Linked ABCG2 Transporter.

T. Hung, S. Ambudkar, Yu-Jen Lu, 2017, Molecular pharmaceutics.

Human ATP-Binding Cassette transporters ABCB1 and ABCG2 confer resistance to CUDC-101, a multi-acting inhibitor of histone deacetylase, epidermal growth factor receptor and human epidermal growth factor receptor 2.

C. Hsieh, chiun-wei Huang, Chung-Pu Wu, 2014, Biochemical pharmacology.

Overexpression of ATP-Binding Cassette Subfamily G Member 2 Confers Resistance to Phosphatidylinositol 3-Kinase Inhibitor PF-4989216 in Cancer Cells.

T. Hung, S. Ambudkar, Chung-Pu Wu, 2017, Molecular pharmaceutics.

The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines.

T. Hung, S. Ambudkar, Chung-Pu Wu, 2018, Cancer letters.

The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.

S. Ambudkar, S. Hsu, Chung-Pu Wu, 2019, Cancer letters.

Human ATP-Binding Cassette Transporter ABCB1 Confers Resistance to Volasertib (BI 6727), a Selective Inhibitor of Polo-like Kinase 1.

C. Hsieh, S. Hsu, chiun-wei Huang, 2015, Molecular pharmaceutics.

Overexpression of human ABCB1 in cancer cells leads to reduced activity of GSK461364, a specific inhibitor of polo-like kinase 1.

C. Hsieh, Chung-Pu Wu, Sung-Han Hsiao, 2014, Molecular pharmaceutics.

Overexpression of Human ABCB1 and ABCG2 Reduces the Susceptibility of Cancer Cells to the Histone Deacetylase 6-Specific Inhibitor Citarinostat

T. Hung, S. Ambudkar, Jau-Song Yu, 2021, International journal of molecular sciences.

SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines.

T. Hung, S. Ambudkar, Chung-Pu Wu, 2018, Cancer letters.

Human ABCB1 (P-glycoprotein) and ABCG2 mediate resistance to BI 2536, a potent and selective inhibitor of Polo-like kinase 1.

S. Ambudkar, Chung-Pu Wu, Sung-Han Hsiao, 2013, Biochemical pharmacology.

Effect of [6]-Gingerol on viral neuraminidase and hemagglutinin-specific T cell immunity in severe influenza

Tse-Ching Chen, A. Dutta, Sung-Han Hsiao, 2022, Phytomedicine Plus.

Human ATP-Binding Cassette Transporter ABCG2 Confers Resistance to CUDC-907, a Dual Inhibitor of Histone Deacetylase and Phosphatidylinositol 3-Kinase.

C. Hsieh, Jau-Song Yu, chiun-wei Huang, 2016, Molecular pharmaceutics.

Tyrphostin RG14620 selectively reverses ABCG2-mediated multidrug resistance in cancer cell lines.

C. Hsieh, S. Ambudkar, Chung-Pu Wu, 2017, Cancer letters.

The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs.

T. Hung, S. Ambudkar, Chung-Pu Wu, 2021, Biochemical pharmacology.

Sitravatinib Sensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Drugs

T. Hung, Chung-Pu Wu, Sung-Han Hsiao, 2020, Cancers.

Avapritinib: A Selective Inhibitor of KIT and PDGFRα that Reverses ABCB1 and ABCG2-Mediated Multidrug Resistance in Cancer Cell Lines.

T. Hung, S. Ambudkar, Jyun-Cheng Wang, 2019, Molecular pharmaceutics.

The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs

T. Hung, S. Ambudkar, Jyun-Cheng Wang, 2019, International journal of molecular sciences.

Branebrutinib (BMS-986195), a Bruton’s Tyrosine Kinase Inhibitor, Resensitizes P-Glycoprotein-Overexpressing Multidrug-Resistant Cancer Cells to Chemotherapeutic Agents

T. Hung, S. Ambudkar, Chung-Pu Wu, 2021, Frontiers in Cell and Developmental Biology.

Erdafitinib Resensitizes ABCB1-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs

T. Hung, Chung-Pu Wu, Sung-Han Hsiao, 2020, Cancers.

Osimertinib (AZD9291) Attenuates the Function of Multidrug Resistance-Linked ATP-Binding Cassette Transporter ABCB1 in Vitro.

C. Hsieh, Chung-Pu Wu, Sung-Han Hsiao, 2016, Molecular pharmaceutics.

Overexpression of ATP-binding cassette transporter ABCG2 as a potential mechanism of acquired resistance to vemurafenib in BRAF(V600E) mutant cancer cells.

S. Ambudkar, S. Hsu, Chung-Pu Wu, 2013, Biochemical pharmacology.

Human ATP‐binding cassette transporters ABCB1 and ABCG2 confer resistance to histone deacetylase 6 inhibitor ricolinostat (ACY‐1215) in cancer cell lines

S. Ambudkar, Jau-Song Yu, Chung-Pu Wu, 2018, Biochemical pharmacology.

Hernandezine, a Bisbenzylisoquinoline Alkaloid with Selective Inhibitory Activity against Multidrug-Resistance-Linked ATP-Binding Cassette Drug Transporter ABCB1.

T. Hung, C. Hsieh, Yu-Jen Lu, 2016, Journal of natural products.

The origin of regulatory from the effector cells in LAG‐3‐marked Th1 immunity against severe influenza virus infection

Tse-Ching Chen, A. Dutta, Sung-Han Hsiao, 2022, Immunology.

An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza

Tse-Ching Chen, A. Dutta, Sung-Han Hsiao, 2023, Communications biology.

Furmonertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, Overcomes Multidrug Resistance through Inhibiting ABCB1 and ABCG2 in Cancer Cells

T. Hung, S. Ambudkar, Chung-Pu Wu, 2023, International journal of molecular sciences.

Relatively preserved functional immune capacity with standard COVID-19 vaccine regimen in people living with HIV

A. Dutta, Sung-Han Hsiao, Ching-Tai Huang, 2023, Frontiers in Immunology.

Perspectives on drug repurposing to overcome cancer multidrug resistance mediated by ABCB1 and ABCG2.

Chung-Pu Wu, Sung-Han Hsiao, Yu-Shan Wu, 2023, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.